Quest Diagnostics 2003 Annual Report Download - page 44

Download and view the complete annual report

Please find page 44 of the 2003 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 109

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109

PART III
Item 10. Directors and Executive Officers of the Registrant
Information concerning the directors of the Company is incorporated by reference to the information in the
Company’s Proxy Statement to be filed on or before April 29, 2004, or the Proxy Statement, appearing under
the caption “Election of Directors’’.
Executive Officers of the Registrant
Officers of the Company are elected annually by the Board of Directors and hold office at the discretion of
the Board of Directors. The following persons serve as executive officers of the Company:
Kenneth W. Freeman (53) is Chairman of the Board and Chief Executive Officer of the Company. Mr.
Freeman joined the Company in May 1995 as President and Chief Executive Officer, was elected a Director in
July 1995 and was elected Chairman of the Board in December 1996. Prior to 1995, he served in a variety of
financial and managerial positions at Corning, which he joined in 1972. He was elected Controller and a Vice
President of Corning in 1985, Senior Vice President in 1987, General Manager of the Science Products Division
in 1989 and Executive Vice President in 1993. He was appointed President and Chief Executive Officer of
Corning Asahi Video Products Company in 1990.
Surya N. Mohapatra, Ph.D. (54) is President and Chief Operating Officer and a Director of the Company.
Prior to joining the Company in February 1999 as Senior Vice President and Chief Operating Officer, he was
Senior Vice President of Picker International, a worldwide leader in advanced medical imaging technologies,
where he served in various executive positions during his 18-year tenure. Dr. Mohapatra was appointed President
and Chief Operating Officer in June 1999.
The Company is implementing an orderly succession plan under which Dr. Mohapatra will succeed Mr.
Freeman as Chief Executive Officer by the date of the 2004 annual meeting of stockholders, scheduled to be
held on May 4, 2004. At that time Mr. Freeman will continue as Chairman of the Board.
Robert A. Hagemann (47) is Senior Vice President and Chief Financial Officer. He joined Corning Life
Sciences, Inc., in 1992, where he held a variety of senior financial positions before being named Vice President
and Corporate Controller of the Company in 1996. Prior to joining the Company, Mr. Hagemann was employed
by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously
associated with Ernst & Young. Mr. Hagemann assumed his present responsibilities in August 1998.
Gerald C. Marrone (61) is Senior Vice President, Administration. Mr. Marrone joined the Company in
November 1997 as Chief Information Officer, after 12 years with Citibank, N.A. He assumed his current
position in October 2002. While at Citibank, he served as Vice President, Division Executive for Citibank’s
Global Production Support Division, and was also the Chief Information Officer of Citibank’s Global Cash
Management business. Prior to joining Citibank, he served for five years as the Chief Information Officer for
Memorial Sloan-Kettering Cancer Center in New York.
Michael E. Prevoznik (42) is Senior Vice President and General Counsel. Prior to joining SBCL in 1994 as
its Chief Legal Compliance Officer, Mr. Prevoznik was with Dechert Price & Rhodes. In 1996, he became Vice
President and Chief Legal Compliance Officer for SmithKline Beecham Healthcare Services. In 1998, he was
appointed Vice President, Compliance for SmithKline Beecham, assuming additional responsibilities for
coordinating all compliance activities within SmithKline Beecham worldwide. Mr. Prevoznik joined the Company
as Vice President and General Counsel in August 1999. In 2003 he assumed additional responsibilities for
corporate communication and governmental affairs.
David M. Zewe (52) is Senior Vice President, Diagnostics Testing Services. Mr. Zewe oversees diagnostic
testing operations company-wide, including physician, clinical trials, international and drugs of abuse testing, as
well as the diagnostic instruments business. Mr. Zewe joined the Company in 1994 as General Manager of the
Philadelphia regional laboratory, became Regional Vice President Sales and Marketing for the mid-Atlantic
region in August 1996, became Vice President, Revenue Services in August 1999, leading the billing function
company-wide, and became Senior Vice President, U.S. Operations in January 2001, responsible for all core
business operations and revenue services. Mr. Zewe assumed his current position in May 2002. Prior to joining
the Company, Mr. Zewe was with the Squibb Diagnostics Division of Bristol Myers Squibb, most recently
serving as Vice President of Sales.
27